Ascendis 製藥公司

SecurityASND / Ascendis Pharma A/S
InstitutionCitigroup Inc
Latest Disclosed Ownership29,701 shares
Latest Disclosed Value $ 6,793,510
Citigroup Inc ownership in ASND / Ascendis Pharma A/S

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 29,701 shares of Ascendis Pharma A/S (US:ASND) valued at $6,793,510 USD as of March 31, 2026. The current value of the position is $6,499,767 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (ASND) in the form of stock options. The firm currently holds call options representing 12,000 of underlying shares valued at $2,744,760 USD and put options representing 12,000 of underlying shares valued at $2,744,760 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ASND / Ascendis Pharma A/S Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 29,701 -1,142 -3.70 6,794 3.30 0.0029
2026-02-13 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 30,843 8,532 38.24 6,577 48.28 0.0029
2025-11-10 2025-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 22,311 -3,788 -14.51 4,436 -1.53 0.0020
2025-08-11 2025-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 26,099 4,935 23.32 4,505 36.57 0.0022
2025-05-12 2025-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 21,164 116 0.55 3,299 13.84 0.0017
2025-02-12 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 21,048 -220 -1.03 2,898 -8.76 0.0017
2024-11-12 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 21,268 -4,013 -15.87 3,176 -7.89 0.0018
2024-08-12 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 25,281 5,305 26.56 3,448 14.18 0.0022
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 19,976 952 5.00 3,020 26.00 0.0020
2024-02-09 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 19,024 -13,553 -41.60 2,396 -21.44 0.0017
2023-12-06 2023-09-30 13F/A-1 ASCENDIS PHARMA A SPONSORED ADR 04351P101 32,577 8,257 33.95 3,051 40.55 0.0023
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 32,577 8,257 3,051 0.0023
2023-08-10 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 24,320 -9,368 -27.81 2,171 -39.92 0.0014
2023-05-11 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 33,688 14,913 79.43 3,612 57.59 0.0025
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 18,775 17,496 1,367.94 2,293 1,636.36 0.0018
2022-11-10 2022-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,279 -318 -19.91 132 -11.41 0.0001
2022-08-10 2022-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,597 -306 -16.08 149 -33.18 0.0001
2022-05-12 2022-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,903 -534 -21.91 223 -32.01 0.0001
2022-02-10 2021-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 2,437 -1,111 -31.31 328 -42.05 0.0002
2021-11-10 2021-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 3,548 -200 -5.34 566 14.81 0.0003
2021-08-10 2021-06-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 3,748 2,408 179.70 493 184.97 0.0003
2021-05-13 2021-03-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,340 -531 -28.38 173 -44.55 0.0001
2021-02-11 2020-12-31 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 1,871 -898 -32.43 312 -26.93 0.0002
2020-11-12 2020-09-30 13F ASCENDIS PHARMA A SPONSORED ADR 04351P101 2,769 -472 -14.56 427 -10.86 0.0003
2020-08-12 2020-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 3,241 422 14.97 479 51.10 0.0004
2020-05-12 2020-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 2,819 -736 -20.70 317 -35.96 0.0003
2020-02-12 2019-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 3,555 2,354 196.00 495 326.72 0.0004
2019-11-08 2019-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,201 154 14.71 116 -4.13 0.0001
2019-08-12 2019-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,047 454 76.56 121 72.86 0.0001
2019-05-13 2019-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 593 593 70 0.0001
2018-08-10 2018-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -142 -100.00 0 -100.00
2018-05-11 2018-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 142 -902 -86.40 9 -78.57 0.0000
2018-02-12 2017-12-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 1,044 1,044 42 0.0000
2016-08-12 2016-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -50 -100.00 0 -100.00
2016-05-13 2016-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 50 50 0.00 1 0.0000
2015-11-13 2015-09-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 0 -42 -100.00 0 -100.00
2015-08-13 2015-06-30 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 42 -38 -47.50 1 0.00 0.0000
2015-05-14 2015-03-31 13F ASCENDIS PHARMA A S SPONSORED ADR 04351P101 80 80 1 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 12,000 -84.19 2,745 -83.04 n/a n/a n/a
2026-02-13 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 75,900 16,185 n/a n/a n/a
2024-11-12 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-12 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 12,500 -49.60 1,705 -54.55 n/a n/a n/a
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 24,800 -12.06 3,749 5.58 n/a n/a n/a
2024-02-09 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 28,200 12.80 3,552 51.69 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ASCENDIS PHARMA A SPONSORED ADR Call 25,000 0.00 2,341 4.93 n/a n/a n/a
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 25,000 2,341 n/a n/a n/a
2023-08-10 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Call 25,000 0.00 2,231 -16.75 n/a n/a n/a
2023-05-11 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 25,000 3.31 2,680 -9.31 n/a n/a n/a
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Call 24,200 2,956 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-11 2026-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 12,000 -40.00 2,745 -35.65 n/a n/a n/a
2026-02-13 2025-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 20,000 4,265 n/a n/a n/a
2025-02-12 2024-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-12 2024-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 2,500 -80.00 373 -78.11 n/a n/a n/a
2024-08-12 2024-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 12,500 -49.60 1,705 -54.55 n/a n/a n/a
2024-05-10 2024-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 24,800 0.00 3,749 20.04 n/a n/a n/a
2024-02-09 2023-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 24,800 -51.94 3,124 -35.35 n/a n/a n/a
2023-12-06 2023-09-30 13F/A ASCENDIS PHARMA A SPONSORED ADR Put 51,600 106.40 4,832 116.54 n/a n/a n/a
2023-11-09 2023-09-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 51,600 4,832 n/a n/a n/a
2023-08-10 2023-06-30 13F ASCENDIS PHARMA A SPONSORED ADR Put 25,000 0.00 2,231 -16.75 n/a n/a n/a
2023-05-11 2023-03-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 25,000 3.31 2,680 -9.31 n/a n/a n/a
2023-02-09 2022-12-31 13F ASCENDIS PHARMA A SPONSORED ADR Put 24,200 2,956 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.